Company Overview and News

 
Hong Kong stocks mark 5-week closing high as trade war, rate hike fears ease

2018-03-12 thehindubusinessline
Hong Kong's benchmark stock index rose nearly 2 per cent to its highest closing level in five weeks on Monday, as fears of a global trade war, and faster US rate hikes eased.

 
Tencent, Cnooc to Join Hang Seng China Index in Major Revamp - Bloomberg

2018-02-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
China shares extend rally for 8th straight day

2018-01-09 thehindubusinessline
China shares on Tuesday were trying to extend a rally to an eighth straight day and were up at midday, helped by gains for consumer and healthcare firms. At 04:03 GMT, the Shanghai Composite index was up 2.76 points or 0.08 per cent at 3,412.24.

 
Hong Kong stocks up for 9th day, close at 10-year high

2018-01-05 thestar.com.my
HONG KONG: Hong Kong stocks rose for a ninth straight session on Friday, aided by strong gains by real estate firms, and the benchmark Hang Seng Index closed at a 10-year high. Chinese appetite for Hong Kong equities, ample cash supply and optimism over share reforms could propel the city's benchmark stock index up as much as 15 percent this year, after an already bullish run in 2017, fund managers and analysts say.

1
China, Hong Kong shares keep climbing; developers lend support

2018-01-05 thehindubusinessline
China and Hong Kong stocks extended their New Year rally on Friday, underpinned by robust gains in real estate firms. At 04:02 GMT, the Shanghai Composite index was up 7.95 points or 0.23 per cent at 3,393.66. China's blue-chip CSI300 index was up 0.24 per cent, with its financial sector sub-index higher by 0.61 per cent, the consumer staples sector down 0.4 per cent , the real estate index up 4.77 per cent and healthcare sub-index up 0.

1
China stocks extend rally; Hong Kong also up

2018-01-03 thehindubusinessline
China and Hong Kong stocks rose further on Wednesday. At 04:02 GMT, the Shanghai Composite index was up 30.46 points or 0.91 per cent at 3,378.79. China's blue-chip CSI300 index was up 1.24 per cent. The financial sector sub-index was 1.1 per cent higher, the consumer staples sector was up 1.67 per cent, the real estate index was up 1.69 per cent and healthcare sub-index was up 0.77 per cent.

 
The 5 Largest Emerging Markets Based FMCG Stocks And Their Battle Against Global Giants

2017-07-24 seekingalpha
Emerging markets are becoming the main drivers for growth of large FMCG companies including Colgate-Palmolive, Unilever, and Procter & Gamble.

 
Adviser says no to corporate takeover proposals

2017-07-10 thestar.com.my
KUB president and group managing director Datuk Abdul Rahim Mohd Zin (pic) also expressed his intention to reject the offer in respect of his entire shareholdings in KUB.

 
Hong Kong’s ‘cheap’ equity valuations could mean this rally has further to run, analysts say

2017-02-17 scmp
Daily turnover on the Hong Kong stock exchange exceeded HK$100 billion on Wednesday and Thursday, more than double the daily averages of January and the daily averages for 2016.

 
WisdomTree China ex-State-Owned Enterprises ETF (CXSE) May Summary

2016-09-17 seekingalpha
Top 10 Holdings as of 4/29/2016: Baidu Inc ADR (BIDU): 9.11%, Ping An Insurance (Group) Co. of China Ltd H (OTCPK:PIAIF): 8.79%, JD.com Inc ADR (JD): 8.39%, Tencent Holdings Ltd. (OTCPK:TCTZF): 7.8%, Alibaba Group Holding Ltd ADR (BABA): 7.79%, Ctrip.com International Ltd ADR (CTRP): 5.75%, Hengan International Group Co Ltd (OTCPK:HEGIF): 2.69%, China Minsheng Banking Corp Ltd H (OTCPK:CGMBF): 2.3%, NetEase Inc ADR (NTES): 2.

 
WisdomTree China ex-State-Owned Enterprises ETF (CXSE) April Summary

2016-09-17 seekingalpha
Top 10 Holdings as of 3/31/2016: Baidu Inc ADR (BIDU): 8.96%, Ping An Insurance (Group) Co. of China Ltd H (OTCPK:PIAIF): 8.91%, JD.com Inc ADR (JD): 8.71%, Alibaba Group Holding Ltd ADR (BABA): 8.04%, Tencent Holdings Ltd. (OTCPK:TCTZF): 7.8%, Ctrip.com International Ltd ADR (CTRP): 5.81%, Hengan International Group Co Ltd (OTCPK:HEGIF): 2.55%, China Minsheng Banking Corp Ltd H (OTCPK:CGMBF): 2.29%, NetEase Inc ADR (NTES): 2.

 
WisdomTree China ex-State-Owned Enterprises ETF (CXSE) June Summary

2016-09-17 seekingalpha
Top 10 Holdings as of 5/31/2016: Tencent Holdings Ltd. (OTCPK:TCTZF): 8.58481%, Baidu Inc ADR (BIDU): 8.46586%, Ping An Insurance (Group) Co. of China Ltd H (OTCPK:PIAIF): 8.40212%, Alibaba Group Holding Ltd ADR (BABA): 8.39867%, JD.com Inc ADR (JD): 8.17121%, Ctrip.com International Ltd ADR (CTRP): 6.09856%, NetEase Inc ADR (NTES): 2.85051%, Hengan International Group Co Ltd (OTCPK:HEGIF): 2.72358%, China Minsheng Banking Corp Ltd H (OTCPK:CGMBF): 2.

 
WisdomTree China ex-State-Owned Enterprises ETF (CXSE) July Summary

2016-09-17 seekingalpha
Top 10 Holdings as of 6/30/2016: Tencent Holdings Ltd. (OTCPK:TCTZF): 8.99243%, Ping An Insurance (Group) Co. of China Ltd H (OTCPK:PIAIF): 8.32846%, Alibaba Group Holding Ltd ADR (BABA): 8.29751%, Baidu Inc ADR (BIDU): 8.09289%, JD.com Inc ADR (JD): 7.18603%, Ctrip.com International Ltd ADR (CTRP): 5.75736%, NetEase Inc ADR (NTES): 3.16258%, China Minsheng Banking Corp Ltd H (OTCPK:CGMBF): 2.61595%, Hengan International Group Co Ltd (OTCPK:HEGIF): 2.

 
Diaper Wars In China: Middle Class Grows - ValueWalk

2016-08-01 valuewalk
The Chinese craze for pricey Japanese-made diapers may change the way you think about investing in developing economies. It’s just one of the many enduring trends we see incubating the next generation of emerging-market winners.

 
Chinese craze for Japanese diapers tells us about emerging markets - Business Insider

2016-07-29 businessinsider
Kao Corp's 'Merries' brand diapers are seen on display with other diaper brands at an Aeon Co Ltd's supermarket outlet in Chiba, east of Tokyo, March 31, 2014. REUTERS/Yuya Shino

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

22h - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

23h - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...